Medicine: Pharmaceutical Drug Medicine (Disambiguation) Academic Medicine (Journal)
Medicine: Pharmaceutical Drug Medicine (Disambiguation) Academic Medicine (Journal)
Medicine: Pharmaceutical Drug Medicine (Disambiguation) Academic Medicine (Journal)
For medicaments,
see Pharmaceutical drug. For other uses, see Medicine
(disambiguation).
"Academic medicine" redirects here. For the journal, see Academic
Medicine (journal).
Medicine
History[edit]
Main article: History of catecholamine research
Extracts of the adrenal gland were first obtained by Polish physiologist Napoleon Cybulski in
1895. These extracts, which he called nadnerczyna("adrenalin"), contained adrenaline and
other catecholamines.[76] American ophthalmologist William H. Bates discovered adrenaline's
usage for eye surgeries prior to 20 April 1896.[77] Japanese chemist Jokichi Takamine and his
assistant Keizo Uenaka independently discovered adrenaline in 1900.[78][79] In 1901,
Takamine successfully isolated and purified the hormone from the adrenal glands of sheep
and oxen.[80] Adrenaline was first synthesized in the laboratory by Friedrich Stolz and Henry
Drysdale Dakin, independently, in 1904.[79]
Pathology[edit]
Increased epinephrine secretion is observed in pheochromocytoma, hypoglycemia,
myocardial infarction and to a lesser degree in benign essential familial tremor. A general
increase in sympathetic neural activity is usually accompanied by increased adrenaline
secretion, but there is selectivity during hypoxia and hypoglycaemia, when the ratio of
adrenaline to noradrenaline is considerably increased.[47][48][49] Therefore, there must be some
autonomy of the adrenal medulla from the rest of the sympathetic system.
Myocardial infarction is associated with high levels of circulating epinephrine and
norepinephrine, particularly in cardiogenic shock.[50][51]
Benign familial tremor (BFT) is responsive to peripheral β adrenergic blockers and β2-
stimulation is known to cause tremor. Patients with BFT were found to have increased
plasma epinephrine, but not norepinephrine.[52][53]
Low, or absent, concentrations of epinephrine can be seen in autonomic neuropathy or
following adrenalectomy. Failure of the adrenal cortex, as with Addisons disease, can
suppress epinephrine secretion as the activity of the synthesing
enzyme, phenylethanolamine-N-methyltransferase, depends on the high concentration of
cortisol that drains from the cortex to the medulla.[54][55][56]
Terminology[edit]
Epinephrine is the pharmaceutical's United States Adopted Name and International
Nonproprietary Name, though the name adrenaline is frequently used. The
term epinephrine was coined by the pharmacologist John Abel (from the Greek for "on top of
the kidneys"), who used the name to describe the extracts he prepared from the adrenal
glands as early as 1897.[57] In 1901, Jokichi Takamine patented a purified adrenal extract,
and called it "adrenalin" (from the Latin for "on top of the kidneys"), which
was trademarked by Parke, Davis & Co in the U.S.[57] In the belief that Abel's extract was the
same as Takamine's, a belief since disputed, epinephrine became[when?] the generic name in
the U.S.[57] The British Approved Name and European Pharmacopoeia term for this drug is
adrenaline and is indeed now one of the few differences between the INN and BAN systems
of names.[58]
Among American health professionals and scientists, the term epinephrine is used
over adrenaline. However, pharmaceuticals that mimic the effects of epinephrine are often
called adrenergics, and receptors for epinephrine are called adrenergic receptors or
adrenoceptors.
Emotional response[edit]
Every emotional response has a behavioral component, an autonomic component, and a
hormonal component. The hormonal component includes the release of epinephrine, an
adrenomedullary response that occurs in response to stress and that is controlled by
the sympathetic nervous system. The major emotion studied in relation to epinephrine is
fear. In an experiment, subjects who were injected with epinephrine expressed more
negative and fewer positive facial expressions to fear films compared to a control group.
These subjects also reported a more intense fear from the films and greater mean intensity
of negative memories than control subjects.[41] The findings from this study demonstrate that
there are learned associations between negative feelings and levels of epinephrine. Overall,
the greater amount of epinephrine is positively correlated with an arousal state of negative
feelings. These findings can be an effect in part that epinephrine elicits physiological
sympathetic responses including an increased heart rate and knee shaking, which can be
attributed to the feeling of fear regardless of the actual level of fear elicited from the video.
Although studies have found a definite relation between epinephrine and fear, other
emotions have not had such results. In the same study, subjects did not express a greater
amusement to an amusement film nor greater anger to an anger film.[41] Similar findings were
also supported in a study that involved rodent subjects that either were able or unable to
produce epinephrine. Findings support the idea that epinephrine does have a role in
facilitating the encoding of emotionally arousing events, contributing to higher levels of
arousal due to fear.[42]
Memory[edit]
It has been found that adrenergic hormones, such as epinephrine, can produce retrograde
enhancement of long-term memory in humans. The release of epinephrine due to
emotionally stressful events, which is endogenous epinephrine, can modulate memory
consolidation of the events, ensuring memory strength that is proportional to memory
importance. Post-learning epinephrine activity also interacts with the degree of arousal
associated with the initial coding.[43] There is evidence that suggests epinephrine does have a
role in long-term stress adaptation and emotional memory encoding specifically. Epinephrine
may also play a role in elevating arousal and fear memory under particular pathological
conditions including post-traumatic stress disorder.[42] Overall, "Extensive evidence indicates
that epinephrine (EPI) modulates memory consolidation for emotionally arousing tasks in
animals and human subjects.”[44] Studies have also found that recognition memory involving
epinephrine depends on a mechanism that depends on β adrenoceptors.[44]Epinephrine does
not readily cross the blood–brain barrier, so its effects on memory consolidation are at least
partly initiated by β adrenoceptors in the periphery. Studies have found that sotalol, a β
adrenoceptor antagonist that also does not readily enter the brain, blocks the enhancing
effects of peripherally administered epinephrine on memory.[45] These findings suggest that β
adrenoceptors are necessary for epinephrine to have an effect on memory consolidation.
LIDOCAINE
Proprietary Name
HYDROCHLORIDE AND EPINEPHRINE
6. Metabolická paměť
je jiný termín pro dlouhodobou paměť (její podstatou je metabolismus bílkovin)
je přetrvávání poškození buněk u diabetu i po normalizaci glykemie
je pojem z evoluční biologie označující funkci starých proteinových domén v
enzymech spojených s evolučně mladými metabolickými cestami
je souhrnný pojem pro imunologickou paměť a další podobné formy v protikladu
k paměti v běžném slova smyslu